Effects of the anti-progestin aglepristone on the uterine tissue of cats administered medroxyprogesterone acetate

Reproduction in Domestic Animals

Volumn 44, Issue SUPPL. 2, 2009, Pages 204-207

  Muphung, W ^a   Rungsipipat, A ^a   Chatdarong, K ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AGLEPRISTONE; CONTRACEPTIVE AGENT; CYCLINE; ESTRANE DERIVATIVE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR;

ANIMAL; CAT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; UTERUS;

ANIMALS; CATS; CONTRACEPTIVE AGENTS, FEMALE; EPITHELIUM; ESTRENES; FEMALE; IMMUNOHISTOCHEMISTRY; MEDROXYPROGESTERONE ACETATE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, PROGESTERONE; UTERUS;

ANIMALIA; FELIDAE;

EID: 67651236800     PISSN: 09366768     EISSN: 14390531     Source Type: Journal    
DOI: 10.1111/j.1439-0531.2009.01411.x     Document Type: Conference Paper

References (16)

1. Breitkopf M, Hoffmann B, Bostedt H, 1997: Treatment of pyometra (cystic endometrial hyperplasia) in bitches with an antiprogestin. J Reprod Fertil Suppl 51, 327 331.
2. Brenner RM, Slayden OD, Critchley HO, 2002: Anti-proliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor. Reproduction 124, 167 172.
3. Cameron ST, Critchley HO, Thong KJ, Buckley CH, Williams AR, Baird DT, 1996: Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum Reprod 11, 2518 2526.
4. Chatdarong K, Rungsipipat A, Axnér E, Linde-Forsberg C, 2005: Hysterographic appearance and uterine histology at different stages of the reproductive cycle and alter progestagen treatment in the domestic cat. Theriogenology 64, 12 29.
5. Chwalisz K, Stöckemann K, Fritzemeier KH, Fuhrmann U, 1998: Modulation of oestrogenic effects by progesterone antagonists in the rat uterus. Human Reprod Update 4, 570 583.
6. De Bosschere H, Ducatelle R, Vermeirsch H, Simoens P, Coryn M, 2002: Estrogen-alpha and progesterone receptor expression in cystic endometrial hyperplasia and pyometra in the bitch. Anim Reprod Sci 70, 251 259. (Pubitemid 34548590)
7. Fieni F, 2006: Clinical evaluation of the use of aglepristone, with or without cloprostenol, to treat cystic endometrial hyperplasia-pyometra complex in bitches. Theriogenology 66, 1550 1556.
8. Fieni F, Martal J, Marnet PG, Siliart B, Guittot F, 2006: Clinical, biological and hormonal study of mid-pregnancy termination in cats with aglepristone. Theriogenology 66, 1721 1728.
9. Galac S, Kooistra HS, Butinar J, Bevers MM, Dieleman SJ, Voorhout G, Okkens AC, 2000: Termination of mid-gestation pregnancy in bitches with aglepristone, a progesterone receptor antagonist. Theriogenology 53, 941 950.
10. Georgiev P, Wehrend A, 2006: Mid-gestation pregnancy termination by the progesterone antagonist aglepristone in queens. Theriogenology 65, 1401 1406.
11. Görlinger S, Kooistra HS, Van den Broek A, Okkens AC, 2002: Treatment of fibroadenomatous hyperplasia in cats with aglepristone. J Vet Intern Med 16, 710 713.
12. Loretti AP, IIha MRS, Ordás J, Martín de las Mulas J, 2005: Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depot medroxyprogesterone acetate. J Feline Med Surg 7, 43 52.
13. Rollón E, Millán Y, De las Mulas JM, 2008: Effects of aglepristone, a progesterone receptor antagonist, in a dog with a vaginal fibroma. J Small Anim Pract 49, 41 43.
14. Romagnoli S, Concannon PW, 2003: Clinical use of progestins in bitches and queens: a review. In: Concannon PW, England G, Verstegen J, Linde-Forsberg C eds Recent Advance in Small Animal Reproduction. Available at: http://www.ivis.org, Ithaca, NY, A1206.0903.
15. Trasch K, Wehrend A, Bostedt H, 2003: Follow-up examinations of bitches after conservative treatment of pyometra with the antigestagen aglepristone. J Vet Med A 50, 375 379. (Pubitemid 41743013)
16. Wehrend A, Hospes R, Gruber AD, 2001: Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone antagonist. Vet Rec 148, 346 347.